Ads
related to: mylanta substitute- What is PCAB
Learn The Novel Mechanism
Of Action Behind PCABs.
- Dosing
Find Out More About Our
Flexible Dosing Options.
- Saving Options
Explore Savings Options
For VOQUEZNA®.
- Safety Profile
How Does VOQUEZNA®
Safety Profile Compare?
- Downloadable Resources
Browse Patient Resources
For Your Patients.
- Clinical Data
Learn More About
VOQUEZNA® Observed Efficacy.
- What is PCAB
Search results
Results From The WOW.Com Content Network
The GI cocktail is a mixture of a viscous anesthetic, an antacid, and an anticholinergic. [1] [2] Common viscous anesthetics use are viscous lidocaine or xylocaine.Common antacids used are magnesium hydroxide, aluminum hydroxide, or simethicone (more commonly known as Mylanta or Maalox). [3]
Mylanta is a brand of over-the-counter drugs for digestive problems, manufactured by Infirst Healthcare USA under license from McNeil Consumer Healthcare, a division of Kenvue (formerly Pfizer since 2007 following its acquisition). [1]
Calcium carbonate antacid tablets. An antacid is a substance which neutralizes stomach acidity and is used to relieve heartburn, indigestion, or an upset stomach. [1] Some antacids have been used in the treatment of constipation and diarrhea. [2]
The antacid, Maalox Maalox was a brand of antacid owned by Sanofi.Their main product is a flavored liquid containing a suspension of aluminum hydroxide and magnesium hydroxide, which act to neutralize or reduce stomach acid, for the purpose of relieving the symptoms of indigestion, heartburn, gastroesophageal reflux disease, and also stomach or duodenal ulcers.
This page was last edited on 22 January 2025, at 13:50 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
The active ingredient in Kaopectate has changed since its original creation. Originally, kaolinite was used as the adsorbent and pectin as the emollient. Attapulgite (a type of absorbent clay) replaced the kaolinite in the 1980s, but was banned by the U.S. Food and Drug Administration in a ruling made in April 2003.
Ad
related to: mylanta substitute